Katherine E. Warren
- Genetics top 0.5%
- Glioma Diagnosis and Treatment 74
- Neurology top 1%
- Neuroblastoma Research and Treatments 32
- Cancer Research top 5%
-
- Advanced MRI Techniques and Applications 10
- Oncology top 5%
-
- Cancer therapeutics and mechanisms 10
- Histone Deacetylase Inhibitors Research 6
-
- Brain Metastases and Treatment 9
-
- Meningioma and schwannoma management 7
-
- Epilepsy research and treatment 6
- Co-authors
- Roger J. PackerFrank M. BalisBrigitte C. WidemannRussell R. LonserStewart GoldmanIan F. PollackAlberta AikinGilbert Vézina
- Cited by
- GeneticsNeurologyCancer Research
- Journals
- Neuro-Oncology (18 papers)Cancer Chemotherapy and Pharmacology (10 papers)Journal of Neuro-Oncology (7 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Katherine E. Warren
114 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 134
- Genetics 1.7k
- Neurology 856
- Cancer Research 364
- Radiology, Nuclear Medicine and Imaging 489
- Oncology 513
Countries citing papers authored by Katherine E. Warren
This map shows the geographic impact of Katherine E. Warren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Warren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Warren more than expected).
Fields of papers citing papers by Katherine E. Warren
This network shows the impact of papers produced by Katherine E. Warren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Warren. The network helps show where Katherine E. Warren may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Katherine E. Warren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2022 | 63 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 6 | |
| 5 | 2020 | 10 | |
| 6 | 2018 | 123 | |
| 7 | 2018 | 84 | |
| 8 | 2018 | 37 | |
| 9 | 2018 | 29 | |
| 10 | 2017 | 3 | |
| 11 | 2016 | 15 | |
| 12 | 2014 | 33 | |
| 13 | 2014 | 11 | |
| 14 | 2012 | 24 | |
| 15 | 2011 | 62 | |
| 16 | 2009 | 3 | |
| 17 | 2009 | 2 | |
| 18 | 2007 | 23 | |
| 19 | 2005 | 33 | |
| 20 | 2001 | 27 |
About Katherine E. Warren
Katherine E. Warren is a scholar working on Genetics, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 116 papers that have together received 3.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (74 papers), Neuroblastoma Research and Treatments (32 papers), Cancer therapeutics and mechanisms (10 papers), Advanced MRI Techniques and Applications (10 papers), Brain Metastases and Treatment (9 papers), Meningioma and schwannoma management (7 papers), Histone Deacetylase Inhibitors Research (6 papers) and Epilepsy research and treatment (6 papers). The work is most often cited by research in Genetics (1.7k citations), Neurology (856 citations) and Cancer Research (364 citations). Katherine E. Warren has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Roger J. Packer, Frank M. Balis, Brigitte C. Widemann, Russell R. Lonser, Stewart Goldman, Ian F. Pollack, Alberta Aikin, Gilbert Vézina, Joanna H. Shih and Tina Young Poussaint. Their work appears in journals such as Neuro-Oncology, Cancer Chemotherapy and Pharmacology, Journal of Neuro-Oncology, Journal of Clinical Oncology and Pediatric Blood & Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.